Radius Health, Inc.
RDUS
RDUS was delisted on the 12th of August, 2022.
133 hedge funds and large institutions have $1.57B invested in Radius Health, Inc. in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 54 increasing their positions, 23 reducing their positions, and 23 closing their positions.
135% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 23
66% more call options, than puts
Call options by funds: $23.7M | Put options by funds: $14.3M
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
4% less funds holding
Funds holding: 138 → 133 (-5)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
23% less capital invested
Capital invested by funds: $2.03B → $1.57B (-$459M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$16.6M |
| 2 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$11M |
| 3 |
D.E. Shaw & Co
New York
|
+$9.87M |
| 4 |
Morgan Stanley
New York
|
+$9.08M |
| 5 |
BlackRock
New York
|
+$7.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$104M |
| 2 |
Millennium Management
New York
|
-$31.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$29.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$24.4M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$20.6M |
RDUS Hedge Fund Activity: Q2 2018 in Review
133 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Radius Health, Inc. (RDUS) for Q2 2018, worth a combined $1.57B — down 23% from $2.03B a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of RDUS and 18 opened new positions — a net loss of 5 holders — while 23 trimmed existing stakes and 54 added.
The largest buyer was Citadel Advisors, adding an estimated $16.6M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $104M sold.
- 133 institutional investors held Radius Health, Inc. (RDUS) as of Q2 2018, down from 138 in Q1 2018.
- Funds reported $1.57B of Radius Health, Inc. stock for Q2 2018, down 23% quarter-over-quarter.
- 18 funds opened new Radius Health, Inc. positions in Q2 2018 and 23 closed out, a net change of -5 holders.
- The largest Radius Health, Inc. buyer in Q2 2018 was Citadel Advisors, an estimated $16.6M added.
- The largest Radius Health, Inc. seller in Q2 2018 was Consonance Capital Management, an estimated $104M sold.
Based on aggregated 13F filings for Q2 2018.